Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Iothalamate

Known as: Iothalamate [Chemical/Ingredient] 
 
National Institutes of Health

Related topics

Related topics

8 relations
Cerebrovascular DisordersDrug AllergyMale Urogenital DiseasesPheochromocytoma

Narrower (3)

Iothalamate MeglumineIothalamate sodium I125Sodium Iothalamate

Broader (1)

Iothalamic Acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.
As part of the Spare-the-Nephron trial, we evaluated the combination mycophenolate mofetil (MMF) and sirolimus (SRL) as a… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.
BACKGROUND AND OBJECTIVES The Chronic Renal Insufficiency Cohort (CRIC) Study was established to examine risk factors for the… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Evaluation of the modification of diet in renal disease study equation in a large diverse population.
Glomerular filtration rate (GFR) estimates facilitate detection of chronic kidney disease. Performance of the Modification of… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.
We performed a randomized prospective trial comparing calcineurin inhibitor (CNI)-free to CNI-based immunosuppression to… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.
Renal function measurements were obtained in 1,703 African Americans with presumed hypertensive nephrosclerosis who were screened… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.
Cystatin C is a nonglycosylated basic protein produced at a constant rate by all investigated nucleated cells. It is freely… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
In studies on the progression of chronic renal failure the measurement of GFR must be very reliable. Sequential determination of… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Early renal medullary hypoxic injury from radiocontrast and indomethacin.
We evaluated the acute changes in cortical and outer medullary oxygen tension and the alterations in renal function and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease…
Assessment of glomerular filtration rate (GFR) with inulin is cumbersome and time-consuming. Radioisotopic filtration markers… Expand
Is this relevant?
Highly Cited
1976
Highly Cited
1976
Comparison of inulin, iothalamate, and 99mTc-DTPA for measurement of glomerular filtration rate.
Clearances of inulin, 125I-iothalamate, and 99mTc-Sn-DTPA were measured simultaneously in five mongrel dogs exhibiting a wide… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE